FMT
LXRX icon

First Mercantile Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

First Mercantile Trust’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,212
Closed -$201K – 811
2017
Q2 		$201K Buy
12,212
+1,227
+11% +$19K 0.04% 565
2017
Q1 		$158K Sell
10,985
-770
-7% -$11.4K 0.02% 636
2016
Q4 		$163K Sell
11,755
-8,058
-41% -$129K 0.03% 624
2016
Q3 		$358K Buy
19,813
+9,113
+85% +$147K 0.05% 468
2016
Q2 		$154K Buy
10,700
+900
+9% +$12.2K 0.02% 654
2016
Q1 		$117K Sell
9,800
-3,600
-27% -$37.7K 0.01% 695
2015
Q4 		$178K Buy
+13,400
New +$165K 0.02% 672

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Mercantile Trust's LXRX Position: Q3 2017 in Review

First Mercantile Trust sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2017, closing a stake of 12,212 shares — an estimated $201K sold.

First Mercantile Trust first reported a position in LXRX in Q4 2015 and held it in 7 quarters. The position peaked at $358K in Q3 2016. 137 funds tracked by Wall St. Rank hold LXRX as of Q3 2017.

  • First Mercantile Trust reported no remaining Lexicon Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • First Mercantile Trust sold 12,212 Lexicon Pharmaceuticals shares in Q3 2017, an estimated $201K.
  • First Mercantile Trust first reported a position in Lexicon Pharmaceuticals in Q4 2015 and held it in 7 quarters.
  • First Mercantile Trust's Lexicon Pharmaceuticals position peaked at $358K in Q3 2016.
  • 137 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2017.

Based on First Mercantile Trust's 13F filing for Q3 2017, filed 13 Nov 2017.